Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan Medical Dialogues Bureau19 Jun 2019 6:31 AM GMTOnline pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan,...
USFDA Caution: Lupin gets OAI letter for MP plant Medical Dialogues Bureau17 March 2019 4:15 AM GMTLupin has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Mandideep (Unit 1) facility...